GVR Report cover Sacroiliac Joint Fusion Market Size, Share & Trends Report

Sacroiliac Joint Fusion Market Size, Share & Trends Analysis Report By Indication (Degenerative Sacroilitis, Sacral Disruption, Trauma), By Surgery Type (MIS, Open), By Product, By End User, By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Dec, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-4-68039-805-9
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 150

Report Overview

The global sacroiliac joint fusion market size was valued at USD 187.5 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 17.5% from 2021 to 2028. Growing technological developments, the number of minimally invasive surgical procedures, reimbursement coverage, and initiatives by key companies are some of the key drivers of this market. As per AmeriHealth Caritas, by 2018, minimally invasive sacroiliac joint fusion was covered by Medicaid programs in 44 states in the U.S. while 32 Blue Cross Blue Shield plans covered minimally invasive joint fusion by 2019. This is anticipated to increase the number of MIS sacroiliac joint fusion procedures.

U.S. sacroiliac joint fusion market size, by indication, 2018 - 2028 (USD Million)

The COVID-19 pandemic significantly impacted the market growth. This included canceled or deferred surgeries, low demand, supply chain challenges, delays in clinical trials, and low sales. For instance, Xtant Medical reported an adverse impact of the outbreak on its business, operating results, and financial performance in 2020. By the second quarter of 2021, however, the company reported a 42% year-on-year rise in revenue largely attributed to the easing of restrictions in key markets, resulting in an increase in elective procedures. The demand for sacroiliac joint fusion products is anticipated to return to pre-COVID numbers as the underlying causes remain unchanged and the volume of elective surgeries recovers in the coming period. Many public and private health institutions have released guidelines to support a smooth and safe resumption of elective procedures. This includes the roadmap for resuming elective surgeries by the American College of Surgeons in collaboration with the Association of periOperative Registered Nurses, ASA, and the American Hospital Association.

SI-BONE, another key player in the market, reported that its operations ran at suboptimal capacity due to the decreased demand for its flagship iFuse product. This was owing to the global restrictions on elective procedures due to the COVID-19 pandemic, in particular during the Q2 of 2020. The company also expensed certain labor and overhead costs, which affected its financial performance. As case volumes began to recover, SI-BONE witnessed a more normalized operations capacity during the second half of 2020. The company initially limited its clinical study expenses from mid-March through April 2020 due to the postponement of trials in hospitals. However, by May 2020, most hospitals allowed the resumption of clinical trials, thus allowing the company to continue its R&D activities during the pandemic.

Technological advancements are also propelling market growth. The growing adoption of new materials and technologies for creating better and safer SI joint fusion systems is anticipated to fuel the market growth over the forecast period. This includes the use of additive manufacturing and 3D printed titanium implants. For instance, the Siros Lateral Sacroiliac Joint Fusion system by Genesys Spinecomprises 3D printed implants that offer optimal stabilization.SI-BONE’s iFuse-3D implants consist of titanium plasma spray-coated 3D implants that mimic native cancellous bone and are based on self-harvesting technology. These additively manufactured 3D-printed implants facilitate an interconnected "bone-like" surface that may improve osteointegration.

Indication Insights

The degenerative sacroilitis segment held the largest revenue share of over 35.0% in 2020. The key factors contributing to this segment growth include a high prevalence of degenerative sacroilitis, growing awareness regarding the condition, and improving diagnostic capabilities for sacroiliac joint disorders. For instance, as per a study published in the National Library of Medicine, the prevalence of sacroiliac joint degeneration was found to be 65.1% in asymptomatic patients and the prevalence steadily increased with age.

The trauma segment is expected to expand at the highest CAGR of 17.7% from 2021 to 2028. Trauma indication is one of the most recently approved indications by the FDA, thus contributing to the segment growth. SI-BONE received FDA clearance for an expanded indication for the iFuse Implant System in March 2020 and a CE mark for a similar indication in January 2021.

Surgery Type Insights

The minimally invasive surgeries (MIS) segment held the largest revenue share of over 90.0% in 2020 and is estimated to expand at the fastest growth rate over the forecast period. The increasing preference for minimally invasive surgeries due to associated benefits such as smaller incisions, reduced pain and scarring, and faster recovery times is the main factor contributing to the segment growth.

According to the Washington State Health Care Authority’s 2021 report, minimally invasive SI joint fusion surgery was found to be more effective than open fusion for reducing pain. It is also associated with a shorter length of stay at the hospital. This combined with the rising number of clinical studies using the MIS approach as compared to the open approach is further anticipated to drive the market.

Product Insights

The implants segment accounted for the largest revenue share of over 70.0% in 2020 and is projected to expand at the highest CAGR over the forecast period. The key factors contributing to the segment growth include the rising demand for safe and effective sacroiliac joint fusion systems and advancements in technology and materials used in these systems.

3D printing technology is gaining popularity in various applications of MIS such as bio modeling to optimize preoperative planning, manufacturing of implants, and hardware templates and guides. In February 2019, for instance, PrinterPrezz, Inc. - a key company involved in metal 3D printing and nanotechnologies, partnered with SI-BONE to provide the latter with development and production services for 3D-printed medical implants and devices.

End-user Insights

The hospitals segment dominated the market with a revenue share of over 45.0% in 2020. The key factors contributing to the segment growth include a higher volume of surgeries performed in hospitals and a growing preference for minimally invasive surgeries. The ) segment is anticipated to register the fastest growth rate of 17.9% over the forecast period. This is attributed to the rising number of ASCsand associated cost-effectiveness.

Global sacroiliac joint fusion market share, by end user, 2020 (%)

According to the Centers for Medicare & Medicaid Services (CMS), in March 2021, there were around 187 Medicare-certified ASCs in Washington state, 442 in Texas, 457 in Florida, 817 in California, and 368 in Georgia. In fact, as per Definitive Healthcare, LLC, there were about 9,280 active ASCs in 2019 in the U.S. These numbers are anticipated to increase over the forecast period. In addition, these centers enable large volumes of surgeries in short periods, thus driving the segment.

Regional Insights

North America held the largest revenue share of over 40.0% in 2020. The growth of the regional market can be attributed to the presence of key players, advanced healthcare infrastructure, and growing reimbursement coverage. Asia Pacific is projected to expand at the fastest CAGRof 19.1% over the forecast period. This is owing to a large patient pool, developing healthcare facilities, and investments by companies.

SI-BONE, Inc. reported the first iFuse procedures beyond its key markets of Europe and the U.S., in countries such as Canada, Israel, Japan, Australia, Hong Kong, New Zealand, Saudi Arabia, South Africa, and Turkey, thus expanding its regional presence. The company has over 7500 customers including surgeons who perform spine and/or pelvic surgery. The company also reported having a reimbursement advantage over its competitors with more than 35 payor exclusives and 300 million lives covered.

Key Companies & Market Share Insights

The market has been characterized by intense competition. Key companies deploy strategic initiatives, such as product development and launches, sales & marketing strategies to increase product awareness, regional expansion, and partnerships to acquire a greater market share. Market players are also involved in conducting clinical testing of their products, patent applications, and increasing product penetration. For instance, in September 2021, PainTEQ was granted 3 patents in the U.S. for its drill-less method of stabilizing an SI joint, abrading device used in the procedure, and allograft implant respectively. All three offerings are used in the company minimally invasive LinQ procedure for SI joint dysfunction, thus solidifying PainTEQ’s position in the market.

In June 2020, Orthofix Medical Inc. launched FIREBIRD SI Fusion System through a limited market release in the U.S. The system uses a 3D printed titanium bone screw that is implanted through a minimally invasive surgery for treating SI joint dysfunction. In October 2020, Orthofix received additional clearance from the FDA for its nanotechnology feature- NANOVATE to be used as part of its FIREBIRD system. This enhanced its offerings. Some prominent players in the global sacroiliac joint fusion market include:

  • SI-BONE, Inc.

  • SIGNUS Medizintechnik GmbH

  • Globus Medical

  • Orthofix Medical Inc.

  • Life Spine, Inc.

  • Camber Spine Technologies, LLC

  • CoreLink Surgical

  • Xtant Medical

  • Surgalign Spine Technologies, Inc.

  • Medtronic

Sacroiliac Joint Fusion Market Report Scope

Report Attribute

Details

Market size value in 2021

USD 214.06 million

Revenue forecast in 2028

USD 661.45 million

Growth Rate

CAGR of 17.5% from 2021 to 2028

Base year for estimation

2020

Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Indication, surgery type, product, end-user, region

Regions covered

North America; Europe; Asia Pacific; Latin America; MEA

Country Scope

U.S.; Canada; U.K.; Germany; Italy; France; Spain; Japan; China; India; Brazil; Mexico; South Africa; Saudi Arabia

Key companies profiled

SI-BONE, Inc.; SIGNUS Medizintechnik GmbH; Globus Medical; Orthofix Medical Inc.; Life Spine, Inc.; Camber Spine Technologies, LLC; CoreLink Surgical; Xtant Medical; Surgalign Spine Technologies, Inc.; Medtronic

Customization scope

Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2028. For the purpose of this report, Grand View Research has segmented the global sacroiliac joint fusion market report on the basis of indication, surgery type, product, end-user, and region:

  • Indication Outlook (Revenue, USD Million, 2016 - 2028)

    • Degenerative Sacroilitis

    • Sacral Disruption

    • Trauma

  • Surgery Type Outlook (Revenue, USD Million, 2016 - 2028)

    • MIS

    • Open

  • Product Outlook (Revenue, USD Million, 2016 - 2028)

    • Implants

    • Accessories

  • End-user Outlook (Revenue, USD Million, 2016 - 2028)

    • Hospitals

    • Ambulatory Surgical Centers

    • Others (Specialty Centers, Research & Academic Institutes)

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • India

      • Japan

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

      • Saudi Arabia

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.